Clinical trial K+31 West - intranasal COVID-19 vaccine
K+31 West clinic (Joint stock company "K 31 City") is undergoing a clinical trial of a new drug - an intranasal vaccine compared to the Gam-COVID-Vac vaccine in healthy volunteers. In August 2020, Gam-COVID-Vac, a combined vector vaccine for the prevention of coronavirus infection, was registered. This drug consists of two components and is injected. The new intranasal vaccine has a number of advantages:
- This method of administration causes the formation of a local and systemic immune response.
- The nose is the entry gate for many pathogens.
- The mucous tissues of an adult contain up to 80% of the number of immune cells.
A volunteer participating in the Study will be observed and treated free of charge by a highly qualified specialist, and will receive free diagnostic support. Each volunteer who successfully completed participation in the study will receive 55,000 (fifty-five thousand) rubles on a bank card.
In order to become a participant in the research program, you must sign up for a free consultation with a general practitioner at the K+31 center by calling the number listed on the contact page. Participation itself is free and completely voluntary. Any participant can refuse to participate in the Study and withdraw from it at any time. The research doctor will talk about all the features of participation in a clinical trial and answer all your questions. You will be required to arrive on time for all scheduled visits.
As you know, no drug can be recommended for use without full-scale clinical trials. It should be noted that phase III is the last one before registration of the medicinal product. We emphasize that this work is carried out in compliance with special international rules of good clinical practice GCP.
Participation in the international program of clinical trials requires high qualifications from the specialists who carry out this work, and the choice of JSC "K 31 City" as a partner speaks of the level of the Center.
The study accepts people with a low titer of antibodies to COVID-19. For convenience, we recommend testing for antibodies to COVID-19 before seeing a doctor.
There are contraindications. Specialist consultation is required.
